School Of Medicine At Mount Sinai Icahn
Insider
- 2024
- Nov 19, 2024
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies School Of Medicine At Mount Sinai Icahn files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Keith A. Meister - $74.03M in WGS purchases and sales in the last 12 months
- Casdin Capital, LLC - $32.57M in WGS purchases and sales in the last 12 months
- Katherine Stueland - $9.37M in WGS purchases and sales in the last 12 months
- Joshua Ruch - $6.09M in WGS purchases and sales in the last 12 months
- Kevin Feeley - $2.60M in WGS purchases and sales in the last 12 months
- Bryan Dechairo - $851K in WGS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is School Of Medicine At Mount Sinai Icahn?
School Of Medicine At Mount Sinai Icahn is a corporate insider of GeneDx Holdings Corp. (WGS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did School Of Medicine At Mount Sinai Icahn last file a Form 4?
The most recent primary Form 4 on record is dated 19 November 2024, one of 3 filings going back to 2024.
Has School Of Medicine At Mount Sinai Icahn been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($75.33M) across all tracked filings.
